skip to Main Content
Phone: 301-655-1084 Email: info@glycomantra.com

GlycoMantra will present at the Oncology Investor Conference.

GlycoMantra will present at the Oncology Investor Conference. GlycoMantra has been selected to pitch at the…

read more

Glycomantra Will Present At RESI Europe

GlycoMantra has been selected to pitch in the Featured Company Pitch Session at RESI Europe meeting.

read more

GlycoMantra received a SBIR Phase 1 grant from the NIDDK (NIH)

GlycoMantra was awarded a SBIR Phase 1 grant to investigate NASH fibrosis.

read more

GlycoMantra received SBIR Phase 1 grant from the NCI (NIH)

July 18, 2018 GlycoMantra received SBIR Phase 1 grant from the NCI (NIH) GlycoMantra was…

read more
Back To Top